 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «1234567891011 |
- ||| Resolute ZES (zotarolimus-eluting stent) / Medtronic
Trial completion, Real-world evidence, Real-world: R-Int: RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population (clinicaltrials.gov) - Apr 17, 2013
P=N/A, N=2349, Completed, Sponsor: Medtronic Vascular
Active, not recruiting --> Completed
- ||| Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment closed: ETAMI: Efficacy of Thrombosuction in Primary Percutaneous Coronary Intervention of Acute Myocardial Infarction (clinicaltrials.gov) - Apr 12, 2013
P4, N=1400, Active, not recruiting, Sponsor: Ajou University School of Medicine
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Resolute ZES (zotarolimus-eluting stent) / Medtronic
New P4 trial: ORIENT: Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent (clinicaltrials.gov) - Apr 4, 2013
P4, N=375, Not yet recruiting, Sponsor: Seoul National University Bundang Hospital
- ||||| Resolute ZES (zotarolimus-eluting stent) / Medtronic
New P4 trial: A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease (PROPEL) (clinicaltrials.gov) - Mar 7, 2013
P4, N=1200, Recruiting, Sponsor: Associations for Establishment of Evidence in Interventions
- Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment change: A New Strategy Regarding Discontinuation of Dual Antiplatelet (clinicaltrials.gov) - Mar 3, 2013
P4, N=982, Completed, Sponsor: Yonsei University
Recruiting --> Active, not recruiting N=2120 --> 982
- Resolute ZES (zotarolimus-eluting stent) / Medtronic
Trial completion: A New Strategy Regarding Discontinuation of Dual Antiplatelet (clinicaltrials.gov) - Mar 3, 2013
P4, N=982, Completed, Sponsor: Yonsei University
N=2120 --> 982 Recruiting --> Completed
- Resolute ZES (zotarolimus-eluting stent) / Medtronic, Xience (everolimus-eluting stent) / Abbott
Enrollment open, Real-world evidence, Real-world: CHOICE: BES, EES, and ZES-R in Real World Practice (clinicaltrials.gov) - Feb 28, 2013
P4, N=2580, Recruiting, Sponsor: Yonsei University
Recruiting --> Completed Active, not recruiting --> Recruiting
- Resolute ZES (zotarolimus-eluting stent) / Medtronic
Trial completion: Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis (clinicaltrials.gov) - Feb 12, 2013
P4, N=80, Completed, Sponsor: Catholic University of the Sacred Heart
Active, not recruiting --> Recruiting Active, not recruiting --> Completed
- ||||| Resolute ZES (zotarolimus-eluting stent) / Medtronic
New P4 trial: ZES for STEMI: Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI (clinicaltrials.gov) - Jan 30, 2013
P4, N=120, Recruiting, Sponsor: Russian Academy of Medical Sciences
- Resolute ZES (zotarolimus-eluting stent) / Medtronic, Xience (everolimus-eluting stent) / Abbott
Trial initiation date, Real-world evidence, Real-world: CHOICE: BES, EES, and ZES-R in Real World Practice (clinicaltrials.gov) - Jan 11, 2013
P4, N=2580, Recruiting, Sponsor: Yonsei University
Active, not recruiting --> Completed Initiation date: Aug 2011 --> Jan 2013
- Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment open: RAMSES: Randomized Trial of Coronary Angioplasty for de Novo Lesions in sMall vesSElS With Drug Eluting Balloon. (clinicaltrials.gov) - Jan 8, 2013
P4, N=290, Recruiting, Sponsor: Andres I
Initiation date: Aug 2011 --> Jan 2013 Not yet recruiting --> Recruiting
- ||| Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment closed: Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) (clinicaltrials.gov) - Dec 19, 2012
P4, N=900, Active, not recruiting, Sponsor: Scripps Health
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- || Resolute ZES (zotarolimus-eluting stent) / Medtronic, Xience (everolimus-eluting stent) / Abbott
New P3 trial: COPERES: COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease (clinicaltrials.gov) - Dec 17, 2012
P3, N=600, Recruiting, Sponsor: Chonbuk National University Hospital
- | Resolute ZES (zotarolimus-eluting stent) / Medtronic, Xience (everolimus-eluting stent) / Abbott
Enrollment open: COPERES: COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease (clinicaltrials.gov) - Dec 17, 2012
P3, N=600, Recruiting, Sponsor: Chonbuk National University Hospital
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | Resolute ZES (zotarolimus-eluting stent) / Medtronic
New P4 trial: A Study Comparing Two Stent on the Degree of Early Stent Healing and Late Lumen Loss.The OCT-ORION Study (clinicaltrials.gov) - Dec 3, 2012
P4, N=60, Recruiting, Sponsor: Prof. Stephen Lee
- Resolute ZES (zotarolimus-eluting stent) / Medtronic
Clinical: Comparison of Double Kissing Culotte Stenting With Double Kissing Crush Stenting for True Bifurcation Lesions (clinicaltrials.gov) - Nov 26, 2012
P=N/A, N=328, Not yet recruiting, Sponsor: Fujian Medical University
- | Resolute ZES (zotarolimus-eluting stent) / Medtronic
New P4 trial: RAMSES: Randomized Trial of Coronary Angioplasty for de Novo Lesions in sMall vesSElS With Drug Eluting Balloon. (clinicaltrials.gov) - Nov 5, 2012
P4, N=290, Recruiting, Sponsor: Andres I
- | Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment closed: Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study (clinicaltrials.gov) - Oct 5, 2012
P3, N=1606, Active, not recruiting, Sponsor: Marco Valgimigli
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Resolute ZES (zotarolimus-eluting stent) / Medtronic, Xience (everolimus-eluting stent) / Abbott
Trial completion: PRODIGY: Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention (clinicaltrials.gov) - Oct 5, 2012
P4, N=1700, Completed, Sponsor: Marco Valgimigli
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Resolute ZES (zotarolimus-eluting stent) / Medtronic
New P4 trial: Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT) (clinicaltrials.gov) - Aug 27, 2012
P4, N=3540, Not yet recruiting, Sponsor: Cardio Research Enschede BV
- ||| Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment closed, Real-world evidence, Real-world: Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients (clinicaltrials.gov) - Aug 16, 2012
P4, N=2400, Active, not recruiting, Sponsor: Associations for Establishment of Evidence in Interventions
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment change: ZEST-LATE: Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation (clinicaltrials.gov) - Aug 6, 2012
P4, N=1175, Completed, Sponsor: Seung-Jung Park
Recruiting --> Active, not recruiting N=2000 --> 1175
- Resolute ZES (zotarolimus-eluting stent) / Medtronic
Trial completion: Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-IV: (LONG-DES-IV) (clinicaltrials.gov) - Aug 5, 2012
P4, N=502, Completed, Sponsor: Seung-Jung Park
N=2000 --> 1175 Active, not recruiting --> Completed
- Resolute ZES (zotarolimus-eluting stent) / Medtronic, Xience (everolimus-eluting stent) / Abbott
Enrollment closed: DUTCH PEERS: DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population (clinicaltrials.gov) - Jul 24, 2012
P4, N=1788, Active, not recruiting, Sponsor: Cardio Research Enschede BV
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Xience (everolimus-eluting stent) / Abbott
Enrollment closed: ZES/EES-OCT: Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence Tomography (clinicaltrials.gov) - May 6, 2012
P4, N=30, Active, not recruiting, Sponsor: Deutsches Herzzentrum Muenchen
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- || Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment change: R-A: RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia (clinicaltrials.gov) - May 1, 2012
P=N/A, N=312, Active, not recruiting, Sponsor: Medtronic Vascular
Recruiting --> Active, not recruiting N=411 --> 312
- || Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment closed: R-A: RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia (clinicaltrials.gov) - May 1, 2012
P=N/A, N=312, Active, not recruiting, Sponsor: Medtronic Vascular
N=411 --> 312 Recruiting --> Active, not recruiting
- |||| Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment open: LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) (clinicaltrials.gov) - Apr 25, 2012
P4, N=400, Recruiting, Sponsor: Seung-Jung Park
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- || Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment change, Real-world evidence, Real-world: R-C Registry: RESOLUTE China Registry: (clinicaltrials.gov) - Apr 23, 2012
P=N/A, N=1800, Active, not recruiting, Sponsor: Medtronic Vascular
Not yet recruiting --> Recruiting N=1258 --> 1800
- || Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment closed, Real-world evidence, Real-world: R-C Registry: RESOLUTE China Registry: (clinicaltrials.gov) - Apr 23, 2012
P=N/A, N=1800, Active, not recruiting, Sponsor: Medtronic Vascular
N=1258 --> 1800 Recruiting --> Active, not recruiting
- | Resolute ZES (zotarolimus-eluting stent) / Medtronic
New P4 trial: CTO-IVUS Study: Impact of Intravascular Ultrasound(IVUS)-Guided Chronic Total Occlusion Intervention With Drug-eluting Stents (clinicaltrials.gov) - Mar 11, 2012
P4, N=400, Recruiting, Sponsor: Yonsei University
- | Resolute ZES (zotarolimus-eluting stent) / Medtronic
New P2 trial: DEBfirst: Comparison of Drug Eluting Balloon and Drug Eluting Stent (clinicaltrials.gov) - Feb 23, 2012
P2, N=180, Recruiting, Sponsor: Seoul National University Bundang Hospital
- ||| Resolute ZES (zotarolimus-eluting stent) / Medtronic
Trial completion: REDES: Assessment of Clinical Performance and Costs of the Endeavor Resolute Stent "in Real Life" in Spain. (clinicaltrials.gov) - Feb 13, 2012
P=N/A, N=448, Completed, Sponsor: Medtronic Bakken Research Center
Recruiting --> Active, not recruiting Recruiting --> Completed
- | Resolute ZES (zotarolimus-eluting stent) / Medtronic, Xience (everolimus-eluting stent) / Abbott
Trial completion: COVER OCT-II: ComparisiOn of Neointimal coVerage betwEen ZES and EES Using OCT at 3 Months (clinicaltrials.gov) - Jan 25, 2012
P4, N=40, Completed, Sponsor: Yonsei University
Recruiting --> Completed Recruiting --> Completed
- Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment closed: ESSENCE-DM2: Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients (clinicaltrials.gov) - Jan 19, 2012
P4, N=260, Active, not recruiting, Sponsor: Seung-Jung Park
Recruiting --> Completed Recruiting --> Active, not recruiting
- || Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment closed, Real-world evidence, Real-world: R-China RCT: RESOLUTE China RCT (clinicaltrials.gov) - Jan 16, 2012
P=N/A, N=400, Active, not recruiting, Sponsor: Medtronic Vascular
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Resolute ZES (zotarolimus-eluting stent) / Medtronic
Trial completion: ISAR-TEST-5: Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis (clinicaltrials.gov) - Jan 3, 2012
P4, N=3002, Completed, Sponsor: Deutsches Herzzentrum Muenchen
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||| Resolute ZES (zotarolimus-eluting stent) / Medtronic
Trial completion, Real-world evidence, Real-world: eFive: E-Five Registry: A World-Wide Registry With The Endeavor Zotarolimus Eluting Coronary Stent (clinicaltrials.gov) - Dec 14, 2011
P=N/A, N=8314, Completed, Sponsor: Medtronic Bakken Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| Resolute ZES (zotarolimus-eluting stent) / Medtronic
New P4 trial: LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) (clinicaltrials.gov) - Dec 8, 2011
P4, N=400, Recruiting, Sponsor: Seung-Jung Park
- Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment change: ESSENCE-DM2: Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients (clinicaltrials.gov) - Dec 7, 2011
P4, N=260, Active, not recruiting, Sponsor: Seung-Jung Park
Active, not recruiting --> Completed N=380 --> 260
- ||| Resolute ZES (zotarolimus-eluting stent) / Medtronic
Trial completion, Real-world evidence, Real-world: China Endeavor Registry: A Registry With The Endeavor Zotarolimus Eluting Coronary Stent in China (clinicaltrials.gov) - Oct 18, 2011
P=N/A, N=2210, Completed, Sponsor: Medtronic Vascular
N=380 --> 260 Active, not recruiting --> Completed
- || Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment change, Real-world evidence, Real-world: R-China RCT: RESOLUTE China RCT (clinicaltrials.gov) - Oct 16, 2011
P=N/A, N=400, Active, not recruiting, Sponsor: Medtronic Vascular
Active, not recruiting --> Completed N=990 --> 400